| Primary |
| Cerebral Infarction |
41.6% |
| Arteriosclerosis Obliterans |
15.1% |
| Peripheral Arterial Occlusive Disease |
10.6% |
| Intermittent Claudication |
8.3% |
| Hypertension |
3.8% |
| Lacunar Infarction |
3.5% |
| Arterial Occlusive Disease |
2.8% |
| Cerebral Artery Stenosis |
1.5% |
| Cerebrovascular Accident |
1.5% |
| Product Used For Unknown Indication |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Myocardial Infarction |
1.2% |
| Myocardial Ischaemia |
1.2% |
| Prophylaxis |
1.1% |
| Angina Pectoris |
1.0% |
| Hyperuricaemia |
1.0% |
| Bradycardia |
0.9% |
| Acute Myocardial Infarction |
0.8% |
| Coronary Arterial Stent Insertion |
0.8% |
| Hyperlipidaemia |
0.8% |
|
| Tachycardia |
10.2% |
| Cardiac Failure |
9.5% |
| Pneumonia |
7.1% |
| Renal Impairment |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| Vomiting |
6.0% |
| Renal Failure Acute |
5.7% |
| Thrombocytopenia |
5.3% |
| Death |
4.9% |
| Interstitial Lung Disease |
4.2% |
| Pulmonary Alveolar Haemorrhage |
3.9% |
| Transient Ischaemic Attack |
3.9% |
| Palpitations |
3.5% |
| Gastric Ulcer Haemorrhage |
3.2% |
| Gastrointestinal Haemorrhage |
3.2% |
| Liver Function Test Abnormal |
3.2% |
| Myocardial Infarction |
3.2% |
| Oedema Peripheral |
3.2% |
| Rash |
3.2% |
| Renal Failure |
3.2% |
|
| Secondary |
| Cerebral Infarction |
18.3% |
| Hypertension |
14.9% |
| Drug Use For Unknown Indication |
10.5% |
| Prophylaxis |
5.5% |
| Renal Transplant |
5.5% |
| Hyperlipidaemia |
4.7% |
| Pneumonia |
4.1% |
| Gastritis |
4.0% |
| Thrombotic Cerebral Infarction |
3.4% |
| Product Used For Unknown Indication |
3.3% |
| Cardiac Failure Chronic |
2.9% |
| Diabetes Mellitus |
2.9% |
| Infection |
2.9% |
| Cardiac Failure |
2.8% |
| Lumbar Spinal Stenosis |
2.6% |
| Glaucoma |
2.4% |
| Angina Pectoris |
2.3% |
| Constipation |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
| Stent Placement |
2.2% |
|
| Interstitial Lung Disease |
11.5% |
| Hepatic Function Abnormal |
8.8% |
| Duodenal Ulcer |
6.8% |
| Liver Disorder |
6.1% |
| Sudden Cardiac Death |
5.4% |
| Thrombocytopenia |
5.4% |
| Urine Output Decreased |
5.4% |
| Renal Impairment |
4.7% |
| Tachycardia |
4.7% |
| Venous Thrombosis |
4.7% |
| Vertigo |
4.7% |
| White Blood Cell Count Decreased |
4.7% |
| White Blood Cell Count Increased |
4.7% |
| Pneumonia |
4.1% |
| Anaemia |
3.4% |
| Medication Error |
3.4% |
| Superinfection |
3.4% |
| Myocardial Infarction |
2.7% |
| Neutrophil Count Decreased |
2.7% |
| Palpitations |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.9% |
| Hypertension |
16.1% |
| Drug Use For Unknown Indication |
13.6% |
| Prophylaxis |
5.8% |
| Diabetes Mellitus |
5.1% |
| Rheumatoid Arthritis |
4.5% |
| Cerebral Infarction |
3.6% |
| Angina Pectoris |
2.8% |
| Insomnia |
2.8% |
| Type 2 Diabetes Mellitus |
2.7% |
| Cardiac Failure |
2.6% |
| Constipation |
2.4% |
| Arteriosclerosis Obliterans |
2.3% |
| Gastritis |
2.1% |
| Hyperlipidaemia |
2.0% |
| Osteoporosis |
2.0% |
| Pain |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Depression |
1.6% |
| Atrial Fibrillation |
1.4% |
|
| Vomiting |
12.3% |
| Interstitial Lung Disease |
8.0% |
| Pyrexia |
7.1% |
| Rhabdomyolysis |
5.4% |
| Death |
5.2% |
| Hypoglycaemia |
5.2% |
| Pneumonia |
5.2% |
| Liver Disorder |
5.0% |
| Renal Failure |
5.0% |
| Myocardial Infarction |
4.5% |
| Renal Impairment |
4.5% |
| Cerebral Infarction |
4.3% |
| Somnolence |
4.0% |
| Ventricular Tachycardia |
4.0% |
| Weight Decreased |
4.0% |
| Nausea |
3.5% |
| Cardiac Failure |
3.3% |
| Tremor |
3.3% |
| Diarrhoea |
3.1% |
| Pain |
3.1% |
|
| Interacting |
| Hypertension |
23.1% |
| Product Used For Unknown Indication |
23.1% |
| Arteritis Obliterans |
7.7% |
| Cerebral Infarction |
7.7% |
| Diabetes Mellitus |
7.7% |
| Epilepsy |
7.7% |
| Lipid Metabolism Disorder |
7.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
7.7% |
| Wound Infection |
7.7% |
|
| Drug Interaction |
25.0% |
| Gastrointestinal Haemorrhage |
25.0% |
| Somnolence |
25.0% |
| Ventricular Tachycardia |
25.0% |
|
